Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
Annals of Oncology2024Vol. 35(7), pp. 588–606
Citations Over TimeTop 1% of 2024 papers
M.F. Mosele, C. Benedikt Westphalen, A Stenzinger, Fabrice Barlési, Ariane Bayle, Ivan Bièche, Jean-François Bonastre, Elena Castro, R. Dienstmann, A. Krämer, Anna M. Czarnecka, Funda Meric‐Bernstam, Stefan Michiels, Rowan Miller, Nicola Normanno, Jorge S. Reis‐Filho, Jordi Remón, Mark E. Robson, E. Rouleau, Aldo Scarpa, C. Serrano, Joaquı́n Mateo, Fabrice André
Abstract
Tumour NGS is increasingly expanding its scope and application within oncology with the aim of enhancing the efficacy of precision medicine for patients with cancer.
Related Papers
- → Management of clinical precision medicine(2021)2 cited
- [ASC-J9 for castration-resistant prostate cancer].(2014)
- Expression of PTTG and its significance in colorectal cancer(2008)
- Androgen Receptor Antagonists for the Treatment of Prostate Cancer(2012)